Skip to content

EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients

EarlySense Monitoring Device Evaluation on Patients in Med / Surg

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00361426
Enrollment
0
Registered
2006-08-08
Start date
2008-01-31
Completion date
2009-02-28
Last updated
2016-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Patients

Keywords

COPD, Respiration Rate, Monitoring

Brief summary

Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.

Detailed description

Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department. During the study the patients' breathing patterns, heart rate, restlessness and cough in sleep will be measured by the EarlySense ES 16 device, which is placed in the patients' bed. Patients' clinical status are followed. The patient's clinical condition is followed and analyzed in comparison to the EarlySense system output in order to determine the capability of the EarlySense system to predict COPD, CHF or Pneumonia deteriorations.

Interventions

DEVICEEarlysense vital sign monitor

The system is a contactless system that measures heart and respiratory rates and other parameters via a contactless sensor that is placed under the patient mattress

Sponsors

The Chaim Sheba Medical Center
CollaboratorOTHER
EarlySense Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* CHF, COPD and Pneumonia Patients or control group non respiratory patients * 18 years old and up * Able to perform spirometry test or connect to ECG, respiratory belt, SPO2 * Willing to sign consent form * Home close to Tel Aviv

Exclusion criteria

* hospitalization within the passing year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026